TFEB and metabolic dysfunction-associated steatohepatitis: Inflammasome activation is also a common characteristic of NASH, and human livers with steatosis or NASH present decreased TFEB and increased p62/SQSTM1, LC3-II, and NLR family pyrin domain containing 3 (NLRP3) expression.